Jesus Saldana
Overview
Explore the profile of Jesus Saldana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Escobar C, Saldana J, Merino J, Peinado R
Drugs Context
. 2025 Mar;
14.
PMID: 40078952
Background: This analysis assesses the effectiveness and tolerability profile of vericiguat in patients with heart failure with reduced ejection fraction (HFrEF) and implantable cardioverter-defibrillator, with an emphasis on the emergence...
2.
Fernandez-Perez I, Giralt-Steinhauer E, Cuadrado-Godia E, Guimaraens L, Vivas E, Saldana J, et al.
J Neurol
. 2024 Sep;
271(10):7064.
PMID: 39231859
No abstract available.
3.
Macias-Gomez A, Jimenez-Balado J, Fernandez-Perez I, Suarez-Perez A, Vallverdu-Prats M, Guimaraens L, et al.
J Neurol Neurosurg Psychiatry
. 2024 Feb;
95(7):675-681.
PMID: 38302433
Background: We aimed to investigate the association between DNA-methylation biological age (B-age) calculated as age acceleration (ageAcc) and key aneurysmal subarachnoid haemorrhage (aSAH) complications such as vasospasm, delayed cerebral ischaemia...
4.
Guimaraens L, Saldana J, Vivas E, Cifuentes S, Balaguer E, Mon D, et al.
J Neurointerv Surg
. 2024 Jan;
17(e1):e159-e165.
PMID: 38228386
Background: The FRED X flow diverter (FREDX), as the second generation in the FRED series, aims to improve the treatment of cerebral aneurysms. This study compares the efficacy and safety...
5.
Fernandez-Perez I, Giralt-Steinhauer E, Cuadrado-Godia E, Guimaraens L, Vivas E, Saldana J, et al.
J Neurol
. 2022 Jul;
269(11):6036-6042.
PMID: 35854138
Background: Spontaneous subarachnoid hemorrhage (SAH) long-term risk is not well known. Our aims are: describing long-term vascular event (VE) incidence rates in SAH survivors; describing VE: ischemic and/or hemorrhagic; identifying...
6.
Guimaraens L, Vivas E, Saldana J, Llibre J, Gil A, Balaguer E, et al.
J Neurointerv Surg
. 2019 Oct;
12(5):521-525.
PMID: 31653756
Purpose: To describe the efficacy and complications of treating cerebral aneurysms with the Flow Re-direction Endoluminal Device (FRED) and to identify predictors for aneurysm occlusion. Methods: A prospective observational registry...
7.
Ois A, Vivas E, Figueras-Aguirre G, Guimaraens L, Cuadrado-Godia E, Avellaneda C, et al.
Stroke
. 2019 Oct;
50(11):3072-3076.
PMID: 31597551
Background and Purpose- Our aim was to describe variables associated with initial misdiagnosis of subarachnoid hemorrhage (SAH). We also analyzed the relationship of misdiagnosis with poor outcome and complications in...